May 2026
The global large molecule drug discovery outsourcing market size was evaluated at USD 3.20 billion in 2025 and is predicted to hit around USD 7.67 billion by 2035, growing at a CAGR of 9.14%.
July 2026
The global drug discovery outsourcing market size was valued at USD 4.45 billion in 2025 and is projected to hit around USD 8.98 billion by 2035 with a CAGR of 7.27%.
April 2026
The global cancer immunotherapy drug discovery outsourcing market size is expected to hit around USD 4.19 billion by 2035 from USD 1.66 billion in 2025, with a CAGR of 9.70%.
January 2026
The global small molecule drug discovery market size is calculated at USD 95.63 billion in 2025 and is projected to hit around USD 204.06 billion by 2035 with a CAGR of 7.87%.
August 2026
The drug discovery services market size was estimated at USD 24.26 billion in 2025 and is expected to hit around USD 89.58 billion by 2035, growing at a CAGR of 13.95% from 2026 to 2035.
August 2026
The global drug discovery market size was evaluated at USD 71.89 billion in 2025 and is projected to hit around USD 171.36 billion by 2035 with a CAGR of 9.07%.
July 2026
The global in-silico drug discovery market size is estimated to hit around USD 11.8 billion by 2035 increasing from USD 4.17 billion in 2025, with a CAGR of 10.96%.
July 2026
The AI-driven drug discovery platforms market is growing as pharmaceutical companies leverage AI to accelerate target identification and lead optimization.
June 2026
The global biomarker discovery outsourcing services market size is evaluated at USD 17.42 billion in 2025 and is predicted to hit around USD 99.38 billion by 2035, growing at a CAGR of 19.02%.
June 2026
The global CNS drug discovery market size was evaluated at USD 9.80 billion in 2025 and is predicted to hit around USD 27.55 billion by 2035, growing at a CAGR of 10.90%.
June 2026
The US drug discovery market size was evaluated at USD 26.24 billion in 2025 and is predicted to hit around USD 63.02 billion by 2035, growing at a CAGR of 9.16%.
May 2026
The global computational medicine and drug discovery software market size was evaluated at USD 10.90 billion in 2025 and is predicted to hit around USD 60.52 billion by 2035, growing at a CAGR of 18.70%.
April 2026
The global drug discovery informatics market size is estimated at USD 4.81 billion in 2025 and is projected to surpass around USD 13.68 billion by 2035 at a CAGR of 11.02%.
March 2026
The global computer-aided drug discovery market size is projevted to hit around USD 14.38 billion by 2035 from USD 4.72 billion in 2025 with a CAGR of 11.78%.
February 2026
The global gastro-retentive drug delivery systems outsourcing market size is expected to increase from USD 2.04 billion in 2025 to hit around USD 3.86 billion by 2035, growing at a CAGR of 6.58%.
January 2026
The generative AI in drug discovery market size reached USD 260.56 million in 2025 and is estimated to hit around USD 2,724.15 million by 2035, at a CAGR of 26.45%.
November 2025
The artificial intelligence (AI) in drug discovery market size is predicted to surpass around USD 17.81 billion by 2035 from USD 6.93 billion in 2025 with a solid CAGR of 9.90%.
August 2025
The U.S. pharmaceutical CDMO market size was calculated at USD 40.52 billion in 2024 and is predicted to reach around USD 83.25 billion by 2034, with a CAGR of 7.47%.
August 2025
The global pharmaceutical CRO market size was evaluated at USD 44.58 billion in 2024 and is projected to attain around USD 91.20 billion by 2034, with a CAGR of 7.42%.
August 2026
The pulmonary alveolar proteinosis (PAP) drugs market reached USD 859.05Â million in 2026, with key pulmonary alveolar proteinosis (PAP) drugs market companies including Savara, Inc., Partner Therapeutics, Inc., Nobelpharma Co., Ltd. Amgen Inc
August 2026
The global antibody drug conjugates market size is projected to hit around USD 34.80 billion by 2035 from USD 12.69 billion in 2025 with a soild CAGR of 10.61%.
August 2026
The business process outsourcing market was valued at USD 347.95 billion in 2025 and is expected to hit around USD 906.27 billion by 2035, with a CAGR of 10.05%.
August 2026
The global subcutaneous drug delivery devices market size was valued at USD 36.12 billion in 2025 and is projected to hit around USD 74.66 billion by 2035 with a CAGR of 7.53%.
August 2026
The global topical drug delivery market size was valued at USD 136.35 billion in 2025 and is expected to hit around USD 324.67 billion by 2035, growing at a CAGR of 9.06%.
August 2026
The global pulmonary drug delivery systems market size is projected to hit around USD 91.51 billion by 2035 from USD 58.33 billion in 2025, with a CAGR of 4.61%.
August 2026
The global knowledge process outsourcing (KPO) market size is projected to hit around USD 404.67 billion by 2035 from USD 125.85 billion in 2025 with a CAGR of 12.39%
August 2026
The Europe over the counter (OTC) drugs market size is calculated at USD 41.44 billion in 2025 and is predicted to attain around USD 74.56 billion by 2035, expanding at a CAGR of 6.05%.
August 2026
The India immunotherapy drugs market size accounted for USD 11.8 billion in 2025 and is predicted to touch around USD 73.67 billion by 2035, growing at a CAGR of 20.10%.
August 2026
The global drug and gene delivery devices market size is projected to hit around USD 1,875.96 million by 2035 from USD 792.67 million in 2025, with a CAGR of 9.00%.
August 2026
The oncology/cancer drugs market size is calculated at USD 192.39 billion in 2025 and is projected to hit around USD 554.69 billion by 2035 with a CAGR of 11.17%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com